Protein Target Identified in Pancreatic Cancer Treatment
Researchers have identified the protein ANO6 as a potential target to curb tumor growth and restore immune system function.
Updated on Oct. 30, 2026 in Cancer
Live Poll
Are recent advances in cancer research making effective new treatments significantly more likely for patients?
Scientists at Fox Chase Cancer Center and the University of Pennsylvania discovered that the protein ANO6 facilitates nutrient transfer that allows pancreatic tumors to thrive. By blocking this protein, researchers successfully reduced tumor weight and immune suppression in mouse models.
Why it matters
Pancreatic tumors often lack functional blood vessels, forcing them to scavenge cholesterol from surrounding cells to survive and suppress immune attacks. Targeting the mechanisms that enable this nutrient theft could provide a vital new strategy for treating aggressive cancers.
Researchers identified two ways ANO6 benefits tumor growth by facilitating the transfer of lipids to cancer cells and enabling immune suppression. Treatment with niclosamide or clofazimine reduced tumor weight in mouse models compared to untreated controls.
The players
Fox Chase Cancer Center
This Philadelphia-based institution is a leading cancer research center that conducted the study on pancreatic ductal adenocarcinoma.
Serge Fuchs
He is a researcher at the University of Pennsylvania who served as a co-author on the study detailing the role of ANO6 in tumor development.
The details
Cancer cells use a process called trogocytosis to nibble membranes from cancer-associated fibroblasts, with ANO6 preparing these membranes for lipid transfer. This process also allows cancer-associated fibroblasts to deplete cholesterol from cytotoxic T lymphocytes, causing T-cell exhaustion.
Timeline
Research findings regarding the ANO6 protein were published in Nature Cancer on October 30, 2026.
The Big Picture
This research shifts the paradigm of pancreatic cancer treatment by moving beyond direct tumor cell targeting to address the metabolic support provided by the surrounding tissue. It updates the long-standing understanding of the fibroblast-rich tumor microenvironment model by pinpointing the specific protein driving the nutrient exchange.
This study identifies potential therapeutic pathways that may eventually lead to new clinical treatments for pancreatic cancer. While currently limited to mouse models, these findings lay the groundwork for future drug development strategies that target tumor nutrient acquisition.
The takeaway
Targeting the specific pathways tumors use to steal nutrients from the body offers a promising new direction for fighting difficult cancers. Future research will focus on whether these laboratory-tested inhibitors can be safely and effectively applied in human patients.
Further reading
For more on the latest research in the field, explore the Cancer section.
Live Poll
Are recent advances in cancer research making effective new treatments significantly more likely for patients?
